A detailed history of Binnacle Investments Inc transactions in Novo Nordisk A S stock. As of the latest transaction made, Binnacle Investments Inc holds 526 shares of NVO stock, worth $35,631. This represents 0.03% of its overall portfolio holdings.

Number of Shares
526
Holding current value
$35,631
% of portfolio
0.03%

Shares

1 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2025

May 13, 2025

BUY
$69.3 - $90.95 $36,451 - $47,839
526 New
526 $36.5 Million

Others Institutions Holding NVO

About NOVO NORDISK A S


  • Ticker NVO
  • Exchange OTC
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 2,257,289,984
  • Market Cap $153B
  • Description
  • Novo Nordisk A/S, a healthcare company, engages in the research, development, manufacture, and marketing of pharmaceutical products worldwide. It operates in two segments, Diabetes and Obesity care, and Biopharm. The Diabetes and Obesity care segment provides products in the areas of insulins, GLP-1 and related delivery systems, oral antidiabeti...
More about NVO
Track This Portfolio

Track Binnacle Investments Inc Portfolio

Follow Binnacle Investments Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Binnacle Investments Inc, based on Form 13F filings with the SEC.

News

Stay updated on Binnacle Investments Inc with notifications on news.